Epstein Secrets

44532 EFTA02574066 "People are shocked whe= they hear that a bag of saline solution costs far less than their cup of =offee in the morning," said Deborah Spak, a spokeswoman for Baxter International, one of three global pharmaceutical companies that ma=e nearly all the IV solutions used in the United State

ting in September, a late start that=worries the executive director of the state's marketplace. "It's a concern that =e're testing this late," said Tom Betlach, who runs the Arizona Health=Care Cost Containment System. "Usually when you do testing, you have to go ahead and address any changes. Given the Oct

ted States each year. “People are shocked when they hear that a bag of saline solution costs far less than their cup of coffee in the morning,” said Deborah Spak, a spokeswoman for Baxter International, one of three global pharmaceutical companies that make nearly all the IV solutions used in the United States

sting in September, a late start that worries the executive director of the state’s marketplace. “It’s a concern that we’re testing this late,” said Tom Betlach, who runs the Arizona Health Care Cost Containment System. “Usually when you do testing, you have to go ahead and address any changes. Given the Oct

ited States each year. "People are shocked when they hear that a bag of saline solution costs far less than their cup of coffee in the morning," said Deborah Spak, a spokeswoman for Baxter International, one of three global pharmaceutical companies that make nearly all the IV solutions used in the United States

esting in September, a late start that worries the executive director of the state's marketplace. "It's a concern that we're testing this late," said Tom Betlach, who runs the Arizona Health Care Cost Containment System. "Usually when you do testing, you have to go ahead and address any changes. Given the Octo